Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
ThermaRx, Inc.
This study will assess the safety and efficacy of ThermaRx heat treatment in subjects who have urinary hesitancy.
The rationale for this approach is based on anecdotal evidence and case reports suggesting that urinary hesitancy can be effectively reduced by external skin heating (hot tub "Jacuzzi" effect, perineal hot water spray). However, to date, there have been no formal studies of this non-invasive form of treatment, and the mechanism of action is still unclear.
This is a two-day study in which each subject will receive an oral fluid load and then one (1) heating treatment with the device. Ultrasound-based measurements of bladder volume will be performed both before and after voiding. On Day 1, voiding will be performed in a standing position; on Day 2, voiding will be done in a sitting position.
Age
25–80
Sex
MALE
Healthy volunteers
Not accepted
You may be eligible if
Male subjects 25-80 years of age at the screening visit.
Subject must have mild-to-moderate urinary hesitancy symptoms (shown as an American Urological Association Symptom Index (AUA-SI) score of 7-19).
Symptoms include (not limited to):
Leaking or dribbling of urine
More frequent urination, especially at night
Urgency to urinate
Urine retention (inability to urinate)
Hesitant, interrupter or weak stream of urine
Inability or difficulty to urinate in public
You may not be if
History of prostate cancer or prostate surgery
Currently (or within the past 30 days) on active treatment for prostate problems